Gestational trophoblastic disease tumours in high risk patients

Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012

Late effects of treatment in gynaecological cancers

Dr Remi Nout – Leiden University Medical Center, Netherlands
Late effects of treatment in gynaecological cancers ( Dr Remi Nout – Leiden University Medical Center, Netherlands )
30 Oct 2012

Staging in endometrial cancer and sentinel node mapping

Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA
Staging in endometrial cancer and sentinel node mapping ( Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA )
30 Oct 2012

OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer

Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain
OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer ( Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain )
30 Oct 2012

Treating platinum resistant ovarian cancer

Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain
Treating platinum resistant ovarian cancer ( Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain )
12 Oct 2012

Nab-paclitaxel and gemcitabine combating pancreatic cancer

Dr Michel Ducreux – Institut Gustave Roussy, Paris, France
Nab-paclitaxel and gemcitabine combating pancreatic cancer ( Dr Michel Ducreux – Institut Gustave Roussy, Paris, France )
12 Oct 2012

Hepatic chemosaturation therapy

Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute of Oncology, Milan, Italy
Hepatic chemosaturation therapy ( Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute of Oncology, Milan, Italy )
11 Oct 2012

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012

Surgical challenges to retroperitoneal sarcomas

Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy
Surgical challenges to retroperitoneal sarcomas ( Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy )
9 Oct 2012

Clinical trials and drug developments in pancreatic cancer

Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy
Clinical trials and drug developments in pancreatic cancer ( Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy )
9 Oct 2012

The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery

Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery ( Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy )
9 Oct 2012

MET inhibitors for non-small cell lung cancer

Prof Georgio Scagliotti – University of Torino, Italy
MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )
9 Oct 2012